BiPER Therapeutics
PrivateLast Round
SAFE
Dec 2, 2025
Total Funding Raised
$3.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BiPER Therapeutics is a biotechnology company that develops first-in-class small molecule therapeutics targeting BiP to treat cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiPER Therapeutics Comparables
Compare BiPER Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EtiraRx | 78% | |
| HiberCell | 77% | |
| SPIMA Therapeutics | 74% |
BiPER Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Dec 2, 2025 | ||||
| Convertible Debt | Dec 17, 2024 | ||||
| Seed | Feb 14, 2023 |
Key People
Founding team and executive leadership
BiPER Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Grew 36% QoQ, from 11 to 15 employees.
- Apr 23, 2026
Grew 40% QoQ, from 10 to 14 employees.
BiPER Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BiPER Therapeutics's valuation, stock price, and market status.
Is BiPER Therapeutics a public or private company?
BiPER Therapeutics is a private company.
What is the current stock price of BiPER Therapeutics?
BiPER Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is BiPER Therapeutics worth (valuation)?
Valuation information for BiPER Therapeutics is not publicly available.
Can I buy BiPER Therapeutics stock?
BiPER Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BiPER Therapeutics's last funding round?
BiPER Therapeutics's most recent funding round was SAFE on December 2, 2025.
Who are the main investors in BiPER Therapeutics?
Key investors in BiPER Therapeutics include MEDIN VC.
Will BiPER Therapeutics IPO soon?
No public IPO plans have been announced for BiPER Therapeutics.
How can I track BiPER Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BiPER Therapeutics's secondary market activity and sign up for updates.